Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Colloids (Blood Plasma) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Global Colloids (Blood Plasma) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Industry: Pharma & Healthcare
Published Date: 2025-03-28
Pages: 196 Pages
Report ld: 4673768
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Colloids (Blood Plasma) Market Size(US$)
CAGR 2025-2031
-2.5%
Market Size,2031
USD 325
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 378 million
Market Forecast in 2031(Value)
US$ 325 million
CAGR
-2.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
In 2024, the global market size of Colloids (Blood Plasma) was estimated to be worth US$ 387 million and is forecast to reach approximately US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.
North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.
The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Colloids (Blood Plasma), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colloids (Blood Plasma).
The Colloids (Blood Plasma) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Colloids (Blood Plasma) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Colloids (Blood Plasma) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
CSL Behring
Baxter
Grifols
Octapharma
Kedrion
Shanghai Raas
CTBB
Hualan Bio
Rongsheng Pharmaceutical
Boya Rongsheng
B. Braun Medical
Fresenius Kabi
HOSPIRA
Axa parenterals
Fresenius Kabi (China)
CR Double-Crane
Kelun Group
Shandong Qidu Pharmaceutical
Shandong Hualu Pharmaceutical
Minsheng Pharma
Kanglepharm
Segment by Type
Natural Type Colloids (Blood Plasma)
Synthetic Type Colloids (Blood Plasma)
Segment by Application
Extensive Burns
Massive Blood or Plasma Loss
Hypovolemic Shock
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Colloids (Blood Plasma) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Colloids (Blood Plasma) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Colloids (Blood Plasma) sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Colloids (Blood Plasma) Product Introduction
1.2 Market by Type
1.2.1 Global Colloids (Blood Plasma) Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Natural Type Colloids (Blood Plasma)
1.2.3 Synthetic Type Colloids (Blood Plasma)
1.3 Market by Application
1.3.1 Global Colloids (Blood Plasma) Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Extensive Burns
1.3.3 Massive Blood or Plasma Loss
1.3.4 Hypovolemic Shock
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Colloids (Blood Plasma) Market Size Estimates and Forecasts
2.1.1 Global Colloids (Blood Plasma) Revenue 2020-2031
2.1.2 Global Colloids (Blood Plasma) Sales 2020-2031
2.2 Colloids (Blood Plasma) Market Size by Region: 2024 Versus 2031
2.3 Colloids (Blood Plasma) Sales by Region (2020-2031)
2.3.1 Global Colloids (Blood Plasma) Sales by Region: 2020-2025
2.3.2 Global Colloids (Blood Plasma) Sales Forecast by Region (2026-2031)
2.3.3 Global Colloids (Blood Plasma) Sales Market Share by Region (2020-2031)
2.4 Colloids (Blood Plasma) Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Colloids (Blood Plasma) Revenue by Region: 2020-2025
2.4.2 Global Colloids (Blood Plasma) Revenue Forecast by Region (2026-2031)
2.4.3 Global Colloids (Blood Plasma) Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Colloids (Blood Plasma) Sales by Type (2020-2031)
3.1.1.1 Global Colloids (Blood Plasma) Sales Volume by Type (2020-2031)
3.1.1.2 Global Colloids (Blood Plasma) Sales Market Share by Type (2020-2031)
3.1.2 Global Colloids (Blood Plasma) Revenue by Type (2020-2031)
3.1.2.1 Global Colloids (Blood Plasma) Revenue by Type (2020-2031)
3.1.2.2 Global Colloids (Blood Plasma) Revenue Market Share by Type (2020-2031)
3.1.3 Colloids (Blood Plasma) Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Colloids (Blood Plasma) Sales by Application (2020-2031)
3.2.1.1 Global Colloids (Blood Plasma) Sales Volume by Application (2020-2031)
3.2.1.2 Global Colloids (Blood Plasma) Sales Market Share by Application (2020-2031)
3.2.2 Global Colloids (Blood Plasma) Revenue by Application (2020-2031)
3.2.2.1 Global Colloids (Blood Plasma) Revenue by Application (2020-2031)
3.2.2.2 Global Colloids (Blood Plasma) Revenue Market Share by Application (2020-2031)
3.2.3 Colloids (Blood Plasma) Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Natural Type Colloids (Blood Plasma) of Colloids (Blood Plasma) Revenue Market Share by Application
3.3.2 Synthetic Type Colloids (Blood Plasma) of Colloids (Blood Plasma) Revenue Market Share by Application
4 Global Colloids (Blood Plasma) by Manufacturers
4.1 Global Top Colloids (Blood Plasma) Manufacturers by Sales (2020-2025)
4.1.1 Global Colloids (Blood Plasma) Sales by Manufacturer (2020-2025)
4.1.2 Global Colloids (Blood Plasma) Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Colloids (Blood Plasma) Manufacturers by Revenue (2020-2025)
4.2.1 Global Colloids (Blood Plasma) Revenue by Manufacturer (2020-2025)
4.2.2 Global Colloids (Blood Plasma) Revenue Share by Manufacturer (2020-2025)
4.3 Global Colloids (Blood Plasma) Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Colloids (Blood Plasma) Manufacturers Covered: Ranking by Revenue
4.4.2 Global Colloids (Blood Plasma) Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Colloids (Blood Plasma) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Colloids (Blood Plasma) Manufacturing Base Distribution, Product Type
4.5.1 Colloids (Blood Plasma) Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Colloids (Blood Plasma) Market
4.5.3 Manufacturers Colloids (Blood Plasma) Product Type and Application
4.5.4 Natural Type Colloids (Blood Plasma) Market Sales of Colloids (Blood Plasma) by Manufacturer
4.5.5 Synthetic Type Colloids (Blood Plasma) Market Sales of Colloids (Blood Plasma) by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 CSL Behring
5.1.1 CSL Behring Company Information
5.1.2 CSL Behring Description, Business Overview
5.1.3 CSL Behring Colloids (Blood Plasma) Products Offered
5.1.4 CSL Behring Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)
5.1.5 CSL Behring Colloids (Blood Plasma) Sales by Product in 2024
5.1.6 CSL Behring Colloids (Blood Plasma) Sales by Application in 2024
5.1.7 CSL Behring Colloids (Blood Plasma) Sales by Geographic Area in 2024
5.1.8 CSL Behring Recent Developments
5.2 Baxter
5.2.1 Baxter Company Information
5.2.2 Baxter Description, Business Overview
5.2.3 Baxter Colloids (Blood Plasma) Products Offered
5.2.4 Baxter Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Baxter Colloids (Blood Plasma) Sales by Product in 2024
5.2.6 Baxter Colloids (Blood Plasma) Sales by Application in 2024
5.2.7 Baxter Colloids (Blood Plasma) Sales by Geographic Area in 2024
5.2.8 Baxter Recent Developments
5.3 Grifols
5.3.1 Grifols Company Information
5.3.2 Grifols Description, Business Overview
5.3.3 Grifols Colloids (Blood Plasma) Products Offered
5.3.4 Grifols Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Grifols Colloids (Blood Plasma) Sales by Product in 2024
5.3.6 Grifols Colloids (Blood Plasma) Sales by Application in 2024
5.3.7 Grifols Colloids (Blood Plasma) Sales by Geographic Area in 2024
5.3.8 Grifols Recent Developments
5.4 Octapharma
5.4.1 Octapharma Company Information
5.4.2 Octapharma Description, Business Overview
5.4.3 Octapharma Colloids (Blood Plasma) Products Offered
5.4.4 Octapharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Octapharma Colloids (Blood Plasma) Sales by Product in 2024
5.4.6 Octapharma Colloids (Blood Plasma) Sales by Application in 2024
5.4.7 Octapharma Colloids (Blood Plasma) Sales by Geographic Area in 2024
5.4.8 Octapharma Recent Developments
5.5 Kedrion
5.5.1 Kedrion Company Information
5.5.2 Kedrion Description, Business Overview
5.5.3 Kedrion Colloids (Blood Plasma) Products Offered
5.5.4 Kedrion Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Kedrion Colloids (Blood Plasma) Sales by Product in 2024
5.5.6 Kedrion Colloids (Blood Plasma) Sales by Application in 2024
5.5.7 Kedrion Colloids (Blood Plasma) Sales by Geographic Area in 2024
5.5.8 Kedrion Recent Developments
5.6 Shanghai Raas
5.6.1 Shanghai Raas Company Information
5.6.2 Shanghai Raas Description, Business Overview
5.6.3 Shanghai Raas Colloids (Blood Plasma) Products Offered
5.6.4 Shanghai Raas Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Shanghai Raas Colloids (Blood Plasma) Sales by Product in 2024
5.6.6 Shanghai Raas Colloids (Blood Plasma) Sales by Application in 2024
5.6.7 Shanghai Raas Colloids (Blood Plasma) Sales by Geographic Area in 2024
5.6.8 Shanghai Raas Recent Developments
5.7 CTBB
5.7.1 CTBB Company Information
5.7.2 CTBB Description, Business Overview
5.7.3 CTBB Colloids (Blood Plasma) Products Offered
5.7.4 CTBB Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)
5.7.5 CTBB Colloids (Blood Plasma) Sales by Product in 2024
5.7.6 CTBB Colloids (Blood Plasma) Sales by Application in 2024
5.7.7 CTBB Colloids (Blood Plasma) Sales by Geographic Area in 2024
5.7.8 CTBB Recent Developments
5.8 Hualan Bio
5.8.1 Hualan Bio Company Information
5.8.2 Hualan Bio Description, Business Overview
5.8.3 Hualan Bio Colloids (Blood Plasma) Products Offered
5.8.4 Hualan Bio Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Hualan Bio Colloids (Blood Plasma) Sales by Product in 2024
5.8.6 Hualan Bio Colloids (Blood Plasma) Sales by Application in 2024
5.8.7 Hualan Bio Colloids (Blood Plasma) Sales by Geographic Area in 2024
5.8.8 Hualan Bio Recent Developments
5.9 Rongsheng Pharmaceutical
5.9.1 Rongsheng Pharmaceutical Company Information
5.9.2 Rongsheng Pharmaceutical Description, Business Overview
5.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Products Offered
5.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales by Product in 2024
5.9.6 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales by Application in 2024
5.9.7 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales by Geographic Area in 2024
5.9.8 Rongsheng Pharmaceutical Recent Developments
5.10 Boya Rongsheng
5.10.1 Boya Rongsheng Company Information
5.10.2 Boya Rongsheng Description, Business Overview
5.10.3 Boya Rongsheng Colloids (Blood Plasma) Products Offered
5.10.4 Boya Rongsheng Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Boya Rongsheng Colloids (Blood Plasma) Sales by Product in 2024
5.10.6 Boya Rongsheng Colloids (Blood Plasma) Sales by Application in 2024
5.10.7 Boya Rongsheng Colloids (Blood Plasma) Sales by Geographic Area in 2024
5.10.8 Boya Rongsheng Recent Developments
5.11 B. Braun Medical
5.11.1 B. Braun Medical Company Information
5.11.2 B. Braun Medical Description, Business Overview
5.11.3 B. Braun Medical Colloids (Blood Plasma) Products Offered
5.11.4 B. Braun Medical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)
5.11.5 B. Braun Medical Colloids (Blood Plasma) Sales by Product in 2024
5.11.6 B. Braun Medical Colloids (Blood Plasma) Sales by Application in 2024
5.11.7 B. Braun Medical Colloids (Blood Plasma) Sales by Geographic Area in 2024
5.11.8 B. Braun Medical Recent Developments
5.12 Fresenius Kabi
5.12.1 Fresenius Kabi Company Information
5.12.2 Fresenius Kabi Description, Business Overview
5.12.3 Fresenius Kabi Colloids (Blood Plasma) Products Offered
5.12.4 Fresenius Kabi Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Fresenius Kabi Colloids (Blood Plasma) Sales by Product in 2024
5.12.6 Fresenius Kabi Colloids (Blood Plasma) Sales by Application in 2024
5.12.7 Fresenius Kabi Colloids (Blood Plasma) Sales by Geographic Area in 2024
5.12.8 Fresenius Kabi Recent Developments
5.13 HOSPIRA
5.13.1 HOSPIRA Company Information
5.13.2 HOSPIRA Description, Business Overview
5.13.3 HOSPIRA Colloids (Blood Plasma) Products Offered
5.13.4 HOSPIRA Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)
5.13.5 HOSPIRA Colloids (Blood Plasma) Sales by Product in 2024
5.13.6 HOSPIRA Colloids (Blood Plasma) Sales by Application in 2024
5.13.7 HOSPIRA Colloids (Blood Plasma) Sales by Geographic Area in 2024
5.13.8 HOSPIRA Recent Developments
5.14 Axa parenterals
5.14.1 Axa parenterals Company Information
5.14.2 Axa parenterals Description, Business Overview
5.14.3 Axa parenterals Colloids (Blood Plasma) Products Offered
5.14.4 Axa parenterals Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Axa parenterals Colloids (Blood Plasma) Sales by Product in 2024
5.14.6 Axa parenterals Colloids (Blood Plasma) Sales by Application in 2024
5.14.7 Axa parenterals Colloids (Blood Plasma) Sales by Geographic Area in 2024
5.14.8 Axa parenterals Recent Developments
5.15 Fresenius Kabi (China)
5.15.1 Fresenius Kabi (China) Company Information
5.15.2 Fresenius Kabi (China) Description, Business Overview
5.15.3 Fresenius Kabi (China) Colloids (Blood Plasma) Products Offered
5.15.4 Fresenius Kabi (China) Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)
5.15.5 Fresenius Kabi (China) Colloids (Blood Plasma) Sales by Product in 2024
5.15.6 Fresenius Kabi (China) Colloids (Blood Plasma) Sales by Application in 2024
5.15.7 Fresenius Kabi (China) Colloids (Blood Plasma) Sales by Geographic Area in 2024
5.15.8 Fresenius Kabi (China) Recent Developments
5.16 CR Double-Crane
5.16.1 CR Double-Crane Company Information
5.16.2 CR Double-Crane Description, Business Overview
5.16.3 CR Double-Crane Colloids (Blood Plasma) Products Offered
5.16.4 CR Double-Crane Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)
5.16.5 CR Double-Crane Colloids (Blood Plasma) Sales by Product in 2024
5.16.6 CR Double-Crane Colloids (Blood Plasma) Sales by Application in 2024
5.16.7 CR Double-Crane Colloids (Blood Plasma) Sales by Geographic Area in 2024
5.16.8 CR Double-Crane Recent Developments
5.17 Kelun Group
5.17.1 Kelun Group Company Information
5.17.2 Kelun Group Description, Business Overview
5.17.3 Kelun Group Colloids (Blood Plasma) Products Offered
5.17.4 Kelun Group Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)
5.17.5 Kelun Group Colloids (Blood Plasma) Sales by Product in 2024
5.17.6 Kelun Group Colloids (Blood Plasma) Sales by Application in 2024
5.17.7 Kelun Group Colloids (Blood Plasma) Sales by Geographic Area in 2024
5.17.8 Kelun Group Recent Developments
5.18 Shandong Qidu Pharmaceutical
5.18.1 Shandong Qidu Pharmaceutical Company Information
5.18.2 Shandong Qidu Pharmaceutical Description, Business Overview
5.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Products Offered
5.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)
5.18.5 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales by Product in 2024
5.18.6 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales by Application in 2024
5.18.7 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales by Geographic Area in 2024
5.18.8 Shandong Qidu Pharmaceutical Recent Developments
5.19 Shandong Hualu Pharmaceutical
5.19.1 Shandong Hualu Pharmaceutical Company Information
5.19.2 Shandong Hualu Pharmaceutical Description, Business Overview
5.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Products Offered
5.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)
5.19.5 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales by Product in 2024
5.19.6 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales by Application in 2024
5.19.7 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales by Geographic Area in 2024
5.19.8 Shandong Hualu Pharmaceutical Recent Developments
5.20 Minsheng Pharma
5.20.1 Minsheng Pharma Company Information
5.20.2 Minsheng Pharma Description, Business Overview
5.20.3 Minsheng Pharma Colloids (Blood Plasma) Products Offered
5.20.4 Minsheng Pharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)
5.20.5 Minsheng Pharma Colloids (Blood Plasma) Sales by Product in 2024
5.20.6 Minsheng Pharma Colloids (Blood Plasma) Sales by Application in 2024
5.20.7 Minsheng Pharma Colloids (Blood Plasma) Sales by Geographic Area in 2024
5.20.8 Minsheng Pharma Recent Developments
5.21 Kanglepharm
5.21.1 Kanglepharm Company Information
5.21.2 Kanglepharm Description, Business Overview
5.21.3 Kanglepharm Colloids (Blood Plasma) Products Offered
5.21.4 Kanglepharm Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2020-2025)
5.21.5 Kanglepharm Colloids (Blood Plasma) Sales by Product in 2024
5.21.6 Kanglepharm Colloids (Blood Plasma) Sales by Application in 2024
5.21.7 Kanglepharm Colloids (Blood Plasma) Sales by Geographic Area in 2024
5.21.8 Kanglepharm Recent Developments
6 North America
6.1 North America Colloids (Blood Plasma) Market Size YoY Growth 2020-2031
6.2 North America Colloids (Blood Plasma) Market Facts & Figures by Country
6.2.1 North America Colloids (Blood Plasma) Sales by Country (2020-2031)
6.2.2 North America Colloids (Blood Plasma) Revenue by Country (2020-2031)
6.3 North America Colloids (Blood Plasma) Sales by Type (2020-2025)
6.4 North America Colloids (Blood Plasma) Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Colloids (Blood Plasma) Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Colloids (Blood Plasma) Market Facts & Figures by Region
7.2.1 Asia-Pacific Colloids (Blood Plasma) Sales by Region (2020-2031)
7.2.2 Asia-Pacific Colloids (Blood Plasma) Revenue by Region (2020-2031)
7.3 Asia-Pacific Colloids (Blood Plasma) Sales by Type (2020-2025)
7.4 Asia-Pacific Colloids (Blood Plasma) Sales by Application (2020-2025)
8 Europe
8.1 Europe Colloids (Blood Plasma) Market Size YoY Growth 2020-2031
8.2 Europe Colloids (Blood Plasma) Market Facts & Figures by Country
8.2.1 Europe Colloids (Blood Plasma) Sales by Country (2020-2031)
8.2.2 Europe Colloids (Blood Plasma) Revenue by Country (2020-2031)
8.3 Europe Colloids (Blood Plasma) Sales by Type (2020-2025)
8.4 Europe Colloids (Blood Plasma) Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Colloids (Blood Plasma) Market Size YoY Growth 2020-2031
9.2 Latin America Colloids (Blood Plasma) Market Facts & Figures by Country
9.2.1 Latin America Colloids (Blood Plasma) Sales by Country (2020-2031)
9.2.2 Latin America Colloids (Blood Plasma) Revenue by Country (2020-2031)
9.3 Latin America Colloids (Blood Plasma) Sales by Type (2020-2025)
9.4 Latin America Colloids (Blood Plasma) Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Colloids (Blood Plasma) Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Colloids (Blood Plasma) Market Facts & Figures by Country
10.2.1 Middle East and Africa Colloids (Blood Plasma) Sales by Country (2020-2031)
10.2.2 Middle East and Africa Colloids (Blood Plasma) Revenue by Country (2020-2031)
10.3 Middle East and Africa Colloids (Blood Plasma) Sales by Type (2020-2025)
10.4 Middle East and Africa Colloids (Blood Plasma) Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Colloids (Blood Plasma) Supply Chain Analysis
11.2 Colloids (Blood Plasma) Key Raw Materials and Upstream Suppliers
11.3 Colloids (Blood Plasma) Clients Analysis
11.4 Colloids (Blood Plasma) Sales Channel and Sales Model Analysis
11.4.1 Colloids (Blood Plasma) Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Colloids (Blood Plasma) Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Colloids (Blood Plasma) Distributors
12 Colloids (Blood Plasma) Market Dynamics
12.1 Colloids (Blood Plasma) Industry Trends
12.2 Colloids (Blood Plasma) Market Drivers
12.3 Colloids (Blood Plasma) Market Challenges
12.4 Colloids (Blood Plasma) Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Colloids (Blood Plasma) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Colloids (Blood Plasma) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Colloids (Blood Plasma) Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Colloids (Blood Plasma) Sales by Region (2020-2025) & (MT)
Table 5. Global Colloids (Blood Plasma) Sales Forecast by Region (2026-2031) & (MT)
Table 6. Global Colloids (Blood Plasma) Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Colloids (Blood Plasma) Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Colloids (Blood Plasma) Sales Volume by Type (2020-2025) & (MT)
Table 9. Global Colloids (Blood Plasma) Sales Volume by Type (2026-2031) & (MT)
Table 10. Global Colloids (Blood Plasma) Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Colloids (Blood Plasma) Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Colloids (Blood Plasma) Sales Volume by Application (2020-2025) & (MT)
Table 13. Global Colloids (Blood Plasma) Sales Volume by Application (2026-2031) & (MT)
Table 14. Global Colloids (Blood Plasma) Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Colloids (Blood Plasma) Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Colloids (Blood Plasma) Sales by Manufacturer (2020-2025) & (MT)
Table 17. Global Colloids (Blood Plasma) Sales Share by Manufacturer (2020-2025)
Table 18. Colloids (Blood Plasma) Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Colloids (Blood Plasma) Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Colloids (Blood Plasma) Price (2020-2025) & (USD/Kg)
Table 21. Ranking of Global Top Colloids (Blood Plasma) Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Colloids (Blood Plasma) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Colloids (Blood Plasma) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colloids (Blood Plasma) as of 2024)
Table 24. Colloids (Blood Plasma) Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Colloids (Blood Plasma) Market
Table 26. Manufacturers Colloids (Blood Plasma) Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. CSL Behring Company Information
Table 29. CSL Behring Description and Business Overview
Table 30. CSL Behring Colloids (Blood Plasma) Product
Table 31. CSL Behring Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 32. CSL Behring Sales Proportion of Colloids (Blood Plasma) by Product in 2024
Table 33. CSL Behring Sales Proportion of Colloids (Blood Plasma) by Application in 2024
Table 34. CSL Behring Sales Proportion of Colloids (Blood Plasma) by Geographic Area in 2024
Table 35. CSL Behring Recent Developments
Table 36. Baxter Company Information
Table 37. Baxter Description and Business Overview
Table 38. Baxter Colloids (Blood Plasma) Product
Table 39. Baxter Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 40. Baxter Sales Proportion of Colloids (Blood Plasma) by Product in 2024
Table 41. Baxter Sales Proportion of Colloids (Blood Plasma) by Application in 2024
Table 42. Baxter Sales Proportion of Colloids (Blood Plasma) by Geographic Area in 2024
Table 43. Baxter Recent Developments
Table 44. Grifols Company Information
Table 45. Grifols Description and Business Overview
Table 46. Grifols Colloids (Blood Plasma) Product
Table 47. Grifols Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 48. Grifols Sales Proportion of Colloids (Blood Plasma) by Product in 2024
Table 49. Grifols Sales Proportion of Colloids (Blood Plasma) by Application in 2024
Table 50. Grifols Sales Proportion of Colloids (Blood Plasma) by Geographic Area in 2024
Table 51. Grifols Recent Developments
Table 52. Octapharma Company Information
Table 53. Octapharma Description and Business Overview
Table 54. Octapharma Colloids (Blood Plasma) Product
Table 55. Octapharma Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 56. Octapharma Sales Proportion of Colloids (Blood Plasma) by Product in 2024
Table 57. Octapharma Sales Proportion of Colloids (Blood Plasma) by Application in 2024
Table 58. Octapharma Sales Proportion of Colloids (Blood Plasma) by Geographic Area in 2024
Table 59. Octapharma Recent Developments
Table 60. Kedrion Company Information
Table 61. Kedrion Description and Business Overview
Table 62. Kedrion Colloids (Blood Plasma) Product
Table 63. Kedrion Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 64. Kedrion Sales Proportion of Colloids (Blood Plasma) by Product in 2024
Table 65. Kedrion Sales Proportion of Colloids (Blood Plasma) by Application in 2024
Table 66. Kedrion Sales Proportion of Colloids (Blood Plasma) by Geographic Area in 2024
Table 67. Kedrion Recent Developments
Table 68. Shanghai Raas Company Information
Table 69. Shanghai Raas Description and Business Overview
Table 70. Shanghai Raas Colloids (Blood Plasma) Product
Table 71. Shanghai Raas Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 72. Shanghai Raas Sales Proportion of Colloids (Blood Plasma) by Product in 2024
Table 73. Shanghai Raas Sales Proportion of Colloids (Blood Plasma) by Application in 2024
Table 74. Shanghai Raas Sales Proportion of Colloids (Blood Plasma) by Geographic Area in 2024
Table 75. Shanghai Raas Recent Developments
Table 76. CTBB Company Information
Table 77. CTBB Description and Business Overview
Table 78. CTBB Colloids (Blood Plasma) Product
Table 79. CTBB Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80. CTBB Sales Proportion of Colloids (Blood Plasma) by Product in 2024
Table 81. CTBB Sales Proportion of Colloids (Blood Plasma) by Application in 2024
Table 82. CTBB Sales Proportion of Colloids (Blood Plasma) by Geographic Area in 2024
Table 83. CTBB Recent Developments
Table 84. Hualan Bio Company Information
Table 85. Hualan Bio Description and Business Overview
Table 86. Hualan Bio Colloids (Blood Plasma) Product
Table 87. Hualan Bio Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 88. Hualan Bio Sales Proportion of Colloids (Blood Plasma) by Product in 2024
Table 89. Hualan Bio Sales Proportion of Colloids (Blood Plasma) by Application in 2024
Table 90. Hualan Bio Sales Proportion of Colloids (Blood Plasma) by Geographic Area in 2024
Table 91. Hualan Bio Recent Developments
Table 92. Rongsheng Pharmaceutical Company Information
Table 93. Rongsheng Pharmaceutical Description and Business Overview
Table 94. Rongsheng Pharmaceutical Colloids (Blood Plasma) Product
Table 95. Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 96. Rongsheng Pharmaceutical Sales Proportion of Colloids (Blood Plasma) by Product in 2024
Table 97. Rongsheng Pharmaceutical Sales Proportion of Colloids (Blood Plasma) by Application in 2024
Table 98. Rongsheng Pharmaceutical Sales Proportion of Colloids (Blood Plasma) by Geographic Area in 2024
Table 99. Rongsheng Pharmaceutical Recent Developments
Table 100. Boya Rongsheng Company Information
Table 101. Boya Rongsheng Description and Business Overview
Table 102. Boya Rongsheng Colloids (Blood Plasma) Product
Table 103. Boya Rongsheng Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 104. Boya Rongsheng Sales Proportion of Colloids (Blood Plasma) by Product in 2024
Table 105. Boya Rongsheng Sales Proportion of Colloids (Blood Plasma) by Application in 2024
Table 106. Boya Rongsheng Sales Proportion of Colloids (Blood Plasma) by Geographic Area in 2024
Table 107. Boya Rongsheng Recent Developments
Table 108. B. Braun Medical Company Information
Table 109. B. Braun Medical Description and Business Overview
Table 110. B. Braun Medical Colloids (Blood Plasma) Product
Table 111. B. Braun Medical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 112. B. Braun Medical Sales Proportion of Colloids (Blood Plasma) by Product in 2024
Table 113. B. Braun Medical Sales Proportion of Colloids (Blood Plasma) by Application in 2024
Table 114. B. Braun Medical Sales Proportion of Colloids (Blood Plasma) by Geographic Area in 2024
Table 115. B. Braun Medical Recent Developments
Table 116. Fresenius Kabi Company Information
Table 117. Fresenius Kabi Description and Business Overview
Table 118. Fresenius Kabi Colloids (Blood Plasma) Product
Table 119. Fresenius Kabi Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 120. Fresenius Kabi Sales Proportion of Colloids (Blood Plasma) by Product in 2024
Table 121. Fresenius Kabi Sales Proportion of Colloids (Blood Plasma) by Application in 2024
Table 122. Fresenius Kabi Sales Proportion of Colloids (Blood Plasma) by Geographic Area in 2024
Table 123. Fresenius Kabi Recent Developments
Table 124. HOSPIRA Company Information
Table 125. HOSPIRA Description and Business Overview
Table 126. HOSPIRA Colloids (Blood Plasma) Product
Table 127. HOSPIRA Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 128. HOSPIRA Sales Proportion of Colloids (Blood Plasma) by Product in 2024
Table 129. HOSPIRA Sales Proportion of Colloids (Blood Plasma) by Application in 2024
Table 130. HOSPIRA Sales Proportion of Colloids (Blood Plasma) by Geographic Area in 2024
Table 131. HOSPIRA Recent Developments
Table 132. Axa parenterals Company Information
Table 133. Axa parenterals Description and Business Overview
Table 134. Axa parenterals Colloids (Blood Plasma) Product
Table 135. Axa parenterals Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 136. Axa parenterals Sales Proportion of Colloids (Blood Plasma) by Product in 2024
Table 137. Axa parenterals Sales Proportion of Colloids (Blood Plasma) by Application in 2024
Table 138. Axa parenterals Sales Proportion of Colloids (Blood Plasma) by Geographic Area in 2024
Table 139. Axa parenterals Recent Developments
Table 140. Fresenius Kabi (China) Company Information
Table 141. Fresenius Kabi (China) Description and Business Overview
Table 142. Fresenius Kabi (China) Colloids (Blood Plasma) Product
Table 143. Fresenius Kabi (China) Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 144. Fresenius Kabi (China) Sales Proportion of Colloids (Blood Plasma) by Product in 2024
Table 145. Fresenius Kabi (China) Sales Proportion of Colloids (Blood Plasma) by Application in 2024
Table 146. Fresenius Kabi (China) Sales Proportion of Colloids (Blood Plasma) by Geographic Area in 2024
Table 147. Fresenius Kabi (China) Recent Developments
Table 148. CR Double-Crane Company Information
Table 149. CR Double-Crane Description and Business Overview
Table 150. CR Double-Crane Colloids (Blood Plasma) Product
Table 151. CR Double-Crane Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 152. CR Double-Crane Sales Proportion of Colloids (Blood Plasma) by Product in 2024
Table 153. CR Double-Crane Sales Proportion of Colloids (Blood Plasma) by Application in 2024
Table 154. CR Double-Crane Sales Proportion of Colloids (Blood Plasma) by Geographic Area in 2024
Table 155. CR Double-Crane Recent Developments
Table 156. Kelun Group Company Information
Table 157. Kelun Group Description and Business Overview
Table 158. Kelun Group Colloids (Blood Plasma) Product
Table 159. Kelun Group Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 160. Kelun Group Sales Proportion of Colloids (Blood Plasma) by Product in 2024
Table 161. Kelun Group Sales Proportion of Colloids (Blood Plasma) by Application in 2024
Table 162. Kelun Group Sales Proportion of Colloids (Blood Plasma) by Geographic Area in 2024
Table 163. Kelun Group Recent Developments
Table 164. Shandong Qidu Pharmaceutical Company Information
Table 165. Shandong Qidu Pharmaceutical Description and Business Overview
Table 166. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product
Table 167. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 168. Shandong Qidu Pharmaceutical Sales Proportion of Colloids (Blood Plasma) by Product in 2024
Table 169. Shandong Qidu Pharmaceutical Sales Proportion of Colloids (Blood Plasma) by Application in 2024
Table 170. Shandong Qidu Pharmaceutical Sales Proportion of Colloids (Blood Plasma) by Geographic Area in 2024
Table 171. Shandong Qidu Pharmaceutical Recent Developments
Table 172. Shandong Hualu Pharmaceutical Company Information
Table 173. Shandong Hualu Pharmaceutical Description and Business Overview
Table 174. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product
Table 175. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 176. Shandong Hualu Pharmaceutical Sales Proportion of Colloids (Blood Plasma) by Product in 2024
Table 177. Shandong Hualu Pharmaceutical Sales Proportion of Colloids (Blood Plasma) by Application in 2024
Table 178. Shandong Hualu Pharmaceutical Sales Proportion of Colloids (Blood Plasma) by Geographic Area in 2024
Table 179. Shandong Hualu Pharmaceutical Recent Developments
Table 180. Minsheng Pharma Company Information
Table 181. Minsheng Pharma Description and Business Overview
Table 182. Minsheng Pharma Colloids (Blood Plasma) Product
Table 183. Minsheng Pharma Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 184. Minsheng Pharma Sales Proportion of Colloids (Blood Plasma) by Product in 2024
Table 185. Minsheng Pharma Sales Proportion of Colloids (Blood Plasma) by Application in 2024
Table 186. Minsheng Pharma Sales Proportion of Colloids (Blood Plasma) by Geographic Area in 2024
Table 187. Minsheng Pharma Recent Developments
Table 188. Kanglepharm Company Information
Table 189. Kanglepharm Description and Business Overview
Table 190. Kanglepharm Colloids (Blood Plasma) Product
Table 191. Kanglepharm Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 192. Kanglepharm Sales Proportion of Colloids (Blood Plasma) by Product in 2024
Table 193. Kanglepharm Sales Proportion of Colloids (Blood Plasma) by Application in 2024
Table 194. Kanglepharm Sales Proportion of Colloids (Blood Plasma) by Geographic Area in 2024
Table 195. Kanglepharm Recent Developments
Table 196. North America Colloids (Blood Plasma) Sales by Country (2020-2025) & (MT)
Table 197. North America Colloids (Blood Plasma) Sales by Country (2026-2031) & (MT)
Table 198. North America Colloids (Blood Plasma) Revenue by Country (2020-2025) & (US$ Million)
Table 199. North America Colloids (Blood Plasma) Revenue by Country (2026-2031) & (US$ Million)
Table 200. North America Colloids (Blood Plasma) Sales by Type (2020-2025) & (MT)
Table 201. North America Colloids (Blood Plasma) Sales by Application (2020-2025) & (MT)
Table 202. Asia-Pacific Colloids (Blood Plasma) Sales by Region (2020-2025) & (MT)
Table 203. Asia-Pacific Colloids (Blood Plasma) Sales by Region (2026-2031) & (MT)
Table 204. Asia-Pacific Colloids (Blood Plasma) Revenue by Region (2020-2025) & (US$ Million)
Table 205. Asia-Pacific Colloids (Blood Plasma) Revenue by Region (2026-2031) & (US$ Million)
Table 206. Asia-Pacific Colloids (Blood Plasma) Sales by Type (2020-2025) & (MT)
Table 207. Asia-Pacific Colloids (Blood Plasma) Sales by Application (2020-2025) & (MT)
Table 208. Europe Colloids (Blood Plasma) Sales by Country (2020-2025) & (MT)
Table 209. Europe Colloids (Blood Plasma) Sales by Country (2026-2031) & (MT)
Table 210. Europe Colloids (Blood Plasma) Revenue by Country (2020-2025) & (US$ Million)
Table 211. Europe Colloids (Blood Plasma) Revenue by Country (2026-2031) & (US$ Million)
Table 212. Europe Colloids (Blood Plasma) Sales by Type (2020-2025) & (MT)
Table 213. Europe Colloids (Blood Plasma) Sales by Application (2020-2025) & (MT)
Table 214. Latin America Colloids (Blood Plasma) Sales by Country (2020-2025) & (MT)
Table 215. Latin America Colloids (Blood Plasma) Sales by Country (2026-2031) & (MT)
Table 216. Latin America Colloids (Blood Plasma) Revenue by Country (2020-2025) & (US$ Million)
Table 217. Latin America Colloids (Blood Plasma) Revenue by Country (2026-2031) & (US$ Million)
Table 218. Latin America Colloids (Blood Plasma) Sales by Type (2020-2025) & (MT)
Table 219. Latin America Colloids (Blood Plasma) Sales by Application (2020-2025) & (MT)
Table 220. Middle East and Africa Colloids (Blood Plasma) Sales by Country (2020-2025) & (MT)
Table 221. Middle East and Africa Colloids (Blood Plasma) Sales by Country (2026-2031) & (MT)
Table 222. Middle East and Africa Colloids (Blood Plasma) Revenue by Country (2020-2025) & (US$ Million)
Table 223. Middle East and Africa Colloids (Blood Plasma) Revenue by Country (2026-2031) & (US$ Million)
Table 224. Middle East and Africa Colloids (Blood Plasma) Sales by Type (2020-2025) & (MT)
Table 225. Middle East and Africa Colloids (Blood Plasma) Sales by Application (2020-2025) & (MT)
Table 226. Colloids (Blood Plasma) Key Raw Materials, Industry Status and Trend
Table 227. Colloids (Blood Plasma) Key Raw Materials and Upstream Suppliers
Table 228. Colloids (Blood Plasma) Clients Status and Trend
Table 229. Colloids (Blood Plasma) Typical Clients
Table 230. Colloids (Blood Plasma) Distributors
Table 231. Colloids (Blood Plasma) Market Trends
Table 232. Colloids (Blood Plasma) Market Drivers
Table 233. Colloids (Blood Plasma) Market Challenges
Table 234. Colloids (Blood Plasma) Market Restraints
Table 235. Research Programs/Design for This Report
Table 236. Key Data Information from Secondary Sources
Table 237. Key Data Information from Primary Sources
Table 238. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Colloids (Blood Plasma) Product Picture
Figure 2. Global Colloids (Blood Plasma) Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Colloids (Blood Plasma) Sales Market Share by Type in 2024 & 2031
Figure 4. Natural Type Colloids (Blood Plasma) Product Picture
Figure 5. Synthetic Type Colloids (Blood Plasma) Product Picture
Figure 6. Global Colloids (Blood Plasma) Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Colloids (Blood Plasma) Sales Market Share by Application in 2024 & 2031
Figure 8. Extensive Burns
Figure 9. Massive Blood or Plasma Loss
Figure 10. Hypovolemic Shock
Figure 11. Others
Figure 12. Colloids (Blood Plasma) Report Years Considered
Figure 13. Global Colloids (Blood Plasma) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Colloids (Blood Plasma) Market Size 2020-2031 (US$ Million)
Figure 15. Global Colloids (Blood Plasma) Sales 2020-2031 (MT)
Figure 16. Global Colloids (Blood Plasma) Sales Market Share Forecast by Region (2020-2031)
Figure 17. Global Colloids (Blood Plasma) Revenue Market Share by Region (2020-2031)
Figure 18. Global Colloids (Blood Plasma) Sales Market Share Forecast by Type (2020-2031)
Figure 19. Global Colloids (Blood Plasma) Revenue Market Share Forecast by Type (2020-2031)
Figure 20. Colloids (Blood Plasma) Average Selling Price (ASP) by Type (2020-2025) & (USD/Kg)
Figure 21. Global Colloids (Blood Plasma) Sales Market Share Forecast by Application (2020-2031)
Figure 22. Global Colloids (Blood Plasma) Revenue Market Share Forecast by Application (2020-2031)
Figure 23. Colloids (Blood Plasma) Average Selling Price (ASP) by Application (2020-2025) & (USD/Kg)
Figure 24. Natural Type Colloids (Blood Plasma) of Colloids (Blood Plasma) Revenue Market Share by Application, 2024 VS 2031
Figure 25. Synthetic Type Colloids (Blood Plasma) of Colloids (Blood Plasma) Revenue Market Share by Application, 2024 VS 2031
Figure 26. Global Colloids (Blood Plasma) Sales Share by Manufacturer in 2024
Figure 27. Colloids (Blood Plasma) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Natural Type Colloids (Blood Plasma) Market Sales Proportion by Manufacturer in 2024
Figure 29. Synthetic Type Colloids (Blood Plasma) Market Sales Proportion by Manufacturer in 2024
Figure 30. North America Colloids (Blood Plasma) Revenue 2020-2031 (US$ Million)
Figure 31. North America Colloids (Blood Plasma) Sales Market Share by Type (2020-2025)
Figure 32. North America Colloids (Blood Plasma) Sales Market Share by Application (2020-2025)
Figure 33. Asia-Pacific Colloids (Blood Plasma) Revenue 2020-2031 (US$ Million)
Figure 34. Asia-Pacific Colloids (Blood Plasma) Sales Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Colloids (Blood Plasma) Revenue Market Share by Region (2020-2031)
Figure 36. Asia-Pacific Colloids (Blood Plasma) Sales Market Share by Type (2020-2025)
Figure 37. Asia-Pacific Colloids (Blood Plasma) Sales Market Share by Application (2020-2025)
Figure 38. Europe Colloids (Blood Plasma) Revenue Growth Rate 2020-2031 (US$ Million)
Figure 39. Europe Colloids (Blood Plasma) Sales Market Share by Country (2020-2031)
Figure 40. Europe Colloids (Blood Plasma) Revenue Market Share by Country (2020-2031)
Figure 41. Europe Colloids (Blood Plasma) Sales Market Share by Type (2020-2025)
Figure 42. Europe Colloids (Blood Plasma) Sales Market Share by Application (2020-2025)
Figure 43. Latin America Colloids (Blood Plasma) Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Latin America Colloids (Blood Plasma) Sales Market Share by Country (2020-2031)
Figure 45. Latin America Colloids (Blood Plasma) Revenue Market Share by Country (2020-2025)
Figure 46. Latin America Colloids (Blood Plasma) Sales Market Share by Type (2020-2025)
Figure 47. Latin America Colloids (Blood Plasma) Sales Market Share by Application (2020-2025)
Figure 48. Middle East and Africa Colloids (Blood Plasma) Revenue Growth Rate 2020-2031 (US$ Million)
Figure 49. Middle East and Africa Colloids (Blood Plasma) Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Colloids (Blood Plasma) Revenue Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Colloids (Blood Plasma) Sales Market Share by Type (2020-2025)
Figure 52. Middle East and Africa Colloids (Blood Plasma) Sales Market Share by Application (2020-2025)
Figure 53. Colloids (Blood Plasma) Supply Chain (Upstream and Downstream Market)
Figure 54. Global Production Market Share of Colloids (Blood Plasma) Raw Materials by Region in 2024
Figure 55. Colloids (Blood Plasma) Distribution Channels
Figure 56. Global Colloids (Blood Plasma) Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 57. Global Colloids (Blood Plasma) Percentage 2020-2031: Online Sales VS Offline Sales
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Colloids (Blood Plasma) market?
The top companies in the global Colloids (Blood Plasma) market are CSL Behring、Baxter、Grifols.
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Colloids (Blood Plasma) market size from 2025 to 2031?
What was the global market size of Colloids (Blood Plasma) in 2031?
What was the global market size of Colloids (Blood Plasma) in 2025?
Related Reports
Global Colloids (Blood Plasma) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Colloids (Blood Plasma) market size was US$ 378 million in 2025 and is forecast to reach a readjusted size of US$ 317 million by 2032 with a CAGR of -2.5% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 114
USD 4250.00
(Single User License)
Global Colloids (Blood Plasma) Market Research Report 2026
The global Colloids (Blood Plasma) market was valued at US$ 378 million in 2025 and is anticipated to reach US$ 317 million by 2032, at a CAGR of -2.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 143
USD 2900.00
(Single User License)
Colloids (Blood Plasma)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Colloids (Blood Plasma) was estimated to be worth US$ 378 million in 2025 and is projected to reach US$ 317 million, growing at a CAGR of -2.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 167
USD 3950.00
(Single User License)
Global Colloids (Blood Plasma) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Colloids (Blood Plasma) market is projected to grow from US$ 387 million in 2024 to US$ 325 million by 2031, at a CAGR of -2.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 189
USD 4900.00
(Single User License)
Global Colloids (Blood Plasma) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Colloids (Blood Plasma) market size was US$ 387 million in 2024 and is forecast to a readjusted size of US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 119
USD 4250.00
(Single User License)
Colloids (Blood Plasma)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Colloids (Blood Plasma) was estimated to be worth US$ 387 million in 2024 and is forecast to a readjusted size of US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 157
USD 3950.00
(Single User License)
Global Colloids (Blood Plasma) Market Research Report 2025
The global market for Colloids (Blood Plasma) was valued at US$ 387 million in the year 2024 and is projected to reach a revised size of US$ 325 million by 2031, growing at a CAGR of -2.5% during the forecast period.
Published Date: 2025-01-16
Pages: 115
USD 2900.00
(Single User License)
Global Colloids (Blood Plasma) Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published Date: 2024-04-17
Pages: 202
USD 5600.00
(Single User License)
Global Colloids (Blood Plasma) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published Date: 2024-04-16
Pages: 192
USD 5900.00
(Single User License)
Global Colloids (Blood Plasma) Market Insights, Forecast to 2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published Date: 2024-04-07
Pages: 125
USD 4900.00
(Single User License)
Global Colloids (Blood Plasma) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Colloids (Blood Plasma) market size was US$ 378 million in 2025 and is forecast to reach a readjusted size of US$ 317 million by 2032 with a CAGR of -2.5% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 114
USD 4250.00 (Single User License)Global Colloids (Blood Plasma) Market Research Report 2026
The global Colloids (Blood Plasma) market was valued at US$ 378 million in 2025 and is anticipated to reach US$ 317 million by 2032, at a CAGR of -2.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 143
USD 2900.00 (Single User License)Colloids (Blood Plasma)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Colloids (Blood Plasma) was estimated to be worth US$ 378 million in 2025 and is projected to reach US$ 317 million, growing at a CAGR of -2.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 167
USD 3950.00 (Single User License)Global Colloids (Blood Plasma) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Colloids (Blood Plasma) market is projected to grow from US$ 387 million in 2024 to US$ 325 million by 2031, at a CAGR of -2.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 189
USD 4900.00 (Single User License)Global Colloids (Blood Plasma) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Colloids (Blood Plasma) market size was US$ 387 million in 2024 and is forecast to a readjusted size of US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 119
USD 4250.00 (Single User License)Colloids (Blood Plasma)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Colloids (Blood Plasma) was estimated to be worth US$ 387 million in 2024 and is forecast to a readjusted size of US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 157
USD 3950.00 (Single User License)Global Colloids (Blood Plasma) Market Research Report 2025
The global market for Colloids (Blood Plasma) was valued at US$ 387 million in the year 2024 and is projected to reach a revised size of US$ 325 million by 2031, growing at a CAGR of -2.5% during the forecast period.
Published: 2025-01-16
Pages: 115
USD 2900.00 (Single User License)Global Colloids (Blood Plasma) Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published: 2024-04-17
Pages: 202
USD 5600.00 (Single User License)Global Colloids (Blood Plasma) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published: 2024-04-16
Pages: 192
USD 5900.00 (Single User License)Global Colloids (Blood Plasma) Market Insights, Forecast to 2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published: 2024-04-07
Pages: 125
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 5900.00
USD 8850.00
USD 11800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now